Aurora Cannabis (ACB) Non Operating Investment Income (2017 - 2022)
Aurora Cannabis (ACB) posted quarterly Non Operating Investment Income of -$1.5 million for Q4 2022, down 130.6% year-over-year from $4.8 million in Q4 2021, and down 10.7% quarter-over-quarter from -$1.3 million in Q3 2022.
Aurora Cannabis (ACB) Non Operating Investment Income (2017 - 2022) Analysis & Trends
Aurora Cannabis (ACB) has reported Non Operating Investment Income for 6 consecutive years, with -$1.5 million the latest figure, recorded in Q4 2022.
- In Q4 2022, Non Operating Investment Income fell 130.6% year-over-year to -$1.5 million; the TTM figure through Dec 2022 stood at -$4.2 million (up 59.96% YoY), while the FY2022 annual figure was -$776138.5, down 108.2% from the prior year.
- Non Operating Investment Income slipped to -$1.5 million in Q4 2022 per ACB's latest filing, from -$1.3 million in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $147.2 million in Q4 2018 and bottomed at -$14.5 million in Q3 2019.
- Historically, Non Operating Investment Income has averaged $14.9 million across 5 years, with a median of -$748950.7 in 2021.
- Annual changes were most pronounced in 2018 — Non Operating Investment Income surged 4955.59% — and 2022, when it slumped 130.6%.
- Aurora Cannabis' Non Operating Investment Income stood at $147.2 million in 2018, then sank by 105.91% to -$8.7 million in 2019, then jumped by 40.52% to -$5.2 million in 2020, then soared by 87.65% to -$638635.5 in 2021, then plunged by 130.6% to -$1.5 million in 2022.
- Business Quant data shows ACB's Non Operating Investment Income at -$1.5 million in Q4 2022, -$1.3 million in Q3 2022, and -$770222.5 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Aurora Cannabis | 235.30 Mn | 162.99 Mn | 25.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -1.47 Mn |
| Dec 31, 2022 | -1.47 Mn |
| Sep 30, 2022 | -1.33 Mn |
| Sep 30, 2022 | -1.33 Mn |
| Jun 30, 2022 | -770,222.52 |
| Jun 30, 2022 | -770,222.52 |
| Dec 31, 2021 | -638,635.55 |
| Dec 31, 2021 | -638,635.55 |
| Sep 30, 2021 | -727,678.93 |
| Sep 30, 2021 | -727,678.93 |
| Jun 30, 2021 | -10.28 Mn |
| Jun 30, 2021 | -10.28 Mn |
| Mar 31, 2021 | 1.13 Mn |
| Mar 31, 2021 | 1.13 Mn |
| Dec 31, 2020 | -5.17 Mn |
| Dec 31, 2020 | -5.17 Mn |
| Sep 30, 2020 | 5.53 Mn |
| Sep 30, 2020 | 5.53 Mn |
| Mar 31, 2020 | -10.68 Mn |
| Mar 31, 2020 | -10.68 Mn |